Publication date: Jul 01, 2024
Data on people suspected with acute respiratory infections (ARIs) from August 2022 to December 2023 in southern China were analyzed. Following the COVID-19 pandemic, the positive detection rates of respiratory pathogens increased to 56. 9%. Influenza A virus (IAV) emerged as the predominant prevalence pathogen (52. 1%), followed by Mycoplasma pneumoniae (Mp: 21. 2%), and SARS-CoV-2 (11. 6%). Mp, IAV, and Human rhinovirus (HRV) infection were the primary etiologies of ARIs patients under age 18, accounting for 49. 4%, 48. 6%, and 21. 7%, respectively. Mp, HRV, Respiratory syncytial virus (RSV), and Adenovirus (ADV) contributed to ARIs cases in virtually every month in this group, with Mp being particularly notable for its consistent presence and high co-infection rate (31. 0%). IAV was predominant in the 19 to 59 age group (88. 6%), SARS-CoV-2 was responsible for most of ARIs in the elderly group (82. 5%). This study provides valuable insights into the dynamic nature of respiratory pathogens post COVID-19 era.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | respiratory infections |
| disease | MESH | COVID-19 pandemic |
| drug | DRUGBANK | Influenza A virus |
| disease | IDO | pathogen |
| disease | MESH | infection |
| disease | VO | Respiratory syncytial virus |
| disease | MESH | co-infection |
| disease | MESH | Acute Disease |
| disease | MESH | Etiology |
| disease | MESH | Influenza |